BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 17210703)

  • 1. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells.
    Kurooka M; Kaneda Y
    Cancer Res; 2007 Jan; 67(1):227-36. PubMed ID: 17210703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticancer immunotherapy using inactivated Sendai virus particles].
    Kurooka M; Kaneda Y
    Uirusu; 2007 Jun; 57(1):19-27. PubMed ID: 18040151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy.
    Kawano H; Komaba S; Kanamori T; Kaneda Y
    BMC Med; 2007 Sep; 5():28. PubMed ID: 17883878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated Sendai virus suppresses murine melanoma growth by inducing host immune responses and down-regulating β-catenin expression.
    Zhang Q; Yuan WF; Zhai GQ; Zhu SY; Xue ZF; Zhu HF; Xu XM
    Biomed Environ Sci; 2012 Oct; 25(5):509-16. PubMed ID: 23122307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
    Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
    Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.
    Flanagan K; Glover RT; Hörig H; Yang W; Kaufman HL
    Vaccine; 2004 Jul; 22(21-22):2894-903. PubMed ID: 15246626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivated Sendai virus strain Tianjin, a novel genotype of Sendai virus, inhibits growth of murine colon carcinoma through inducing immune responses and apoptosis.
    Shi L; Chen J; Zhong Q; Li M; Geng P; He J; Han Z; Sheng M; Tang H
    J Transl Med; 2013 Sep; 11():205. PubMed ID: 24007528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemagglutinating virus of Japan-envelope containing programmed cell death-ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma.
    Sugii N; Matsuda M; Okumura G; Shibuya A; Ishikawa E; Kaneda Y; Matsumura A
    Cancer Sci; 2021 Jan; 112(1):81-90. PubMed ID: 33155337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
    Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antitumor effects of regulatory T cell blockade combined with pemetrexed in murine malignant mesothelioma.
    Anraku M; Tagawa T; Wu L; Yun Z; Keshavjee S; Zhang L; Johnston MR; de Perrot M
    J Immunol; 2010 Jul; 185(2):956-66. PubMed ID: 20548032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances and developments in the antitumor effect of the HVJ envelope vector on malignant melanoma: from the bench to clinical application.
    Tanemura A; Kiyohara E; Katayama I; Kaneda Y
    Cancer Gene Ther; 2013 Nov; 20(11):599-605. PubMed ID: 24157924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus.
    Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y
    J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
    Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
    Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-tumor effect of Sendai virus Tianjin strain defective interfering particles on tumor-bearing mice].
    Shi L; Chen J; Zhong Q; Geng P; He J
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):177-82. PubMed ID: 24785276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma.
    Matsuda M; Nimura K; Shimbo T; Hamasaki T; Yamamoto T; Matsumura A; Kaneda Y
    J Neurooncol; 2011 May; 103(1):19-31. PubMed ID: 20730616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma.
    Takehara Y; Satoh T; Nishizawa A; Saeki K; Nakamura M; Masuzawa M; Kaneda Y; Katayama I; Yokozeki H
    Clin Immunol; 2013 Oct; 149(1):1-10. PubMed ID: 23886549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of a novel immune-stimulatory pseudovirion suppresses lung metastatic melanoma by regionally enhancing IFN-γ production.
    Saga K; Tamai K; Yamazaki T; Kaneda Y
    Clin Cancer Res; 2013 Feb; 19(3):668-79. PubMed ID: 23251005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.